Zacks Ranks Archer Daniels Midland a Strong Sell, Generali Boosts Stake 146.4%
On January 5, 2026, Zacks added Archer Daniels Midland Company to its Rank #5 (Strong Sell) list. Generali Asset Management SPA SGR increased its Q3 stake by 146.4% to 41,989 shares valued at $2.51 million.
1. Generali Asset Management SPA SGR Boosts Position
Generali Asset Management SPA SGR increased its holdings in Archer Daniels Midland Company by 146.4% during the third quarter, acquiring an additional 24,946 shares to bring its total to 41,989 shares. At the end of the period, that stake was valued at $2,508,000, reflecting the firm’s bullish view on ADM’s midstream processing and agricultural solutions businesses.
2. Major Institutional Investors Adjust Stakes
Several other large funds modified their positions in ADM during recent quarters. Dodge & Cox initiated a new stake valued at $345,689,000 in the second quarter, while Norges Bank deployed $340,247,000 into the company. Pacer Advisors Inc. executed an extraordinary purchase of 4,354,844 shares in Q3, raising its total holding to 4,405,427 shares (worth $263,180,000). MEAG Munich Ergo invested $39,094,000 in Q2 and Charles Schwab Investment Management increased its position by 3.6%, adding 620,794 shares to reach 18,076,118 shares valued at $954,058,000. Institutional investors now control 78.28% of shares outstanding.
3. Q3 Financial Results and FY2025 Guidance
ADM reported third-quarter earnings per share of $0.92, topping consensus estimates by $0.03, on revenue of $20.37 billion versus analyst projections of $20.96 billion. Net margin stood at 1.43% and return on equity was 8.01%. Year-over-year quarterly revenue rose 2.2%. Management set full-year 2025 EPS guidance in a range of 3.250 to 3.500, while the consensus forecast for the fiscal year is 4.31 EPS.
4. Dividend Policy and Analyst Ratings
The company declared a quarterly dividend of $0.51 per share, paid on December 11th to shareholders of record as of November 19th, representing an annualized dividend of $2.04 and a yield of 3.5%, with a payout ratio of 83.27%. On the analyst front, JPMorgan Chase & Co. maintained an underweight recommendation with a $59.00 price objective, Morgan Stanley downgraded its view to underweight with a $50.00 target, UBS reiterated a buy rating, Weiss Ratings issued a hold (c), and Zacks Research moved to a strong sell stance. The consensus rating is Reduce with an average price target of $54.38.